29/04/2022
As part of Multiple Sclerosis Awareness Week (25 April - 1 May), we would like to share some fantastic advancements! The National Institute for Health and Care Excellence (NICE) approved diroximel fumarate (Vumerity) as a new treatment for relapsing MS in adults with active disease in England.
We're pleased NICE has approved Vumerity, which can be taken as a tablet at home, for use on the NHS in England.
Find out more: https://mssoc.uk/3E6Xvol
Today the National Institute for Health and Care Excellence (NICE) approved diroximel fumarate (Vumerity) as a new treatment for relapsing MS in adults with active disease.